EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Stage‐Specific Prognosis and Treatment Outcomes in Extramammary Paget's Disease: A Retrospective Single‐Center Study of 104 Japanese Patients

Manami Takahashi-Watanabe, Taku Fujimura iD, Airi Kobayashi iD, Emi Yamazaki iD, Erika Tamabuchi, Yusuke Muto iD, Yumi Kambayashi, Yoshihide Asano iD

The Journal of Dermatology · 15.11.2026

DOI: 10.1111/1346-8138.70565 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Dermatology, online erschienen am 15.11.2026. Verfasst von Manami Takahashi-Watanabe und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extramammary Paget's disease (EMPD) is a rare cutaneous malignancy for which evidence regarding stage‐specific prognosis and treatment outcomes remains limited. We retrospectively analyzed 104 patients with EMPD treated at a single Japanese institution between November 2012 and December 2025. Progression‐free survival (PFS), overall survival (OS), and treatment responses were evaluated. The cohort comprised 56 patients with Stage 0, 23 with Stage I, 11 with Stage II, seven with Stage III, six with Stage IV, and one with unclassified disease. Both PFS and OS decreased significantly with advancing stage (log‐rank test, both p < 0.0001). Eleven patients with residual or recurrent ill‐defined lesions or who declined surgery received topical imiquimod. Five patients achieved a complete response, corresponding to a complete response rate of 45.5% (95% confidence interval [CI], 16.7%–76.6%); three had non‐CR/non‐PD, and the remaining three had PD, manifesting as local progression and/or lymph node metastasis. Eleven patients with Stage IV disease or distant recurrence received systemic therapy. Docetaxel was the most frequently used first‐line regimen and achieved an overall response rate of 60.0% (3/5; 95% CI, 14.7%–94.7%), although treatment discontinuation due to adverse events was common. None of the three patients who received second‐line nivolumab achieved an objective response. These findings demonstrate a marked deterioration in prognosis with advancing EMPD stage. Imiquimod may provide clinical benefit in carefully selected patients with ill‐defined lesions who are unsuitable for surgery, whereas currently available systemic therapies have limited durability and tolerability. Larger multicenter prospective studies are warranted to establish optimal treatment strategies for EMPD.

Schlagwörter

Stichwörter der Autor:innen

extramammary Paget's diseaseimiquimodprognosissystemic therapytreatment outcomes

Autor:innen und Institutionen

  • Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan.

ORCID-Profile: Taku Fujimura, Airi Kobayashi, Emi Yamazaki, Yusuke Muto, Yoshihide Asano

Zitieren

APA

Takahashi-Watanabe, M., Fujimura, T., Kobayashi, A., Yamazaki, E., Tamabuchi, E., Muto, Y., Kambayashi, Y., & Asano, Y. (2026). Stage‐Specific Prognosis and Treatment Outcomes in Extramammary Paget's Disease: A Retrospective Single‐Center Study of 104 Japanese Patients. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.70565

Vancouver

Takahashi-Watanabe M, Fujimura T, Kobayashi A, Yamazaki E, Tamabuchi E, Muto Y, et al. Stage‐Specific Prognosis and Treatment Outcomes in Extramammary Paget's Disease: A Retrospective Single‐Center Study of 104 Japanese Patients. The Journal of Dermatology. 2026. doi:10.1111/1346-8138.70565

BibTeX
@article{TakahashiWatanabe2026,
  author = {Takahashi-Watanabe, Manami and Fujimura, Taku and Kobayashi, Airi and Yamazaki, Emi and Tamabuchi, Erika and Muto, Yusuke and Kambayashi, Yumi and Asano, Yoshihide},
  title = {Stage‐Specific Prognosis and Treatment Outcomes in Extramammary Paget's Disease: A Retrospective Single‐Center Study of 104 Japanese Patients},
  journal = {The Journal of Dermatology},
  year = {2026},
  doi = {10.1111/1346-8138.70565}
}
Kostenlos starten →